Get the Stockscreener App
0.00
100.00%
-27.49
After Hours:
27.49
27.49
+
Silk Road Medical Inc stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
Silk Road Medical Inc is a medical device company focused on reducing the risk of stroke and its devastating impact. The company has a new approach for the treatment of carotid artery disease called transcarotid artery revascularization, or TCAR, which it seeks to establish as the standard of care. TCAR relies on two novel concepts - minimally-invasive direct carotid access in the neck and high-rate blood flow reversal during the procedure to protect the brain - and combines novel endovascular techniques with fundamental surgical principles. TCAR using its portfolio of products has been clinically demonstrated to reduce the upfront morbidity and mortality risks commonly associated with carotid endarterectomy. The company generates all of its revenue in the United States.
See More
Previous Close:
$27.49
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$1.12B
Revenue:
$177.13M
Net Income/Loss:
$-55.74M
P/E Ratio:
0.00
EPS:
-1.45
Net Cash Flow:
$-33.52M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$27.51
Silk Road Medical Inc Stock (SILK) Company Profile
Name
Silk Road Medical Inc
Sector
Industry
Phone
(650) 566-9060
Address
1213 INNSBRUCK DR., SUNNYVALE, CA
Compare SILK with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SILK
Silk Road Medical Inc
|
0.00 | 1.12B | 177.13M | -55.74M | -33.52M | -1.45 |
|
ABT
Abbott Laboratories
|
113.02 | 196.03B | 41.22B | 5.77B | 6.49B | 3.29 |
|
BSX
Boston Scientific Corp
|
95.65 | 140.97B | 15.91B | 1.79B | 1.89B | 1.21 |
|
SYK
Stryker Corp
|
362.80 | 138.31B | 21.97B | 3.59B | 3.21B | 9.33 |
|
MDT
Medtronic Plc
|
85.25 | 109.31B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
71.04 | 41.90B | 6.60B | 4.16B | 490.10M | 6.93 |
Silk Road Medical Inc Stock (SILK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-21-23 | Downgrade | Argus | Buy → Hold |
| Sep-06-23 | Initiated | Oppenheimer | Outperform |
| Jul-12-23 | Downgrade | BofA Securities | Buy → Underperform |
| Jul-12-23 | Downgrade | JP Morgan | Overweight → Neutral |
| May-23-23 | Initiated | CL King | Buy |
| May-15-23 | Downgrade | Wolfe Research | Peer Perform → Underperform |
| Apr-03-23 | Upgrade | Citigroup | Neutral → Buy |
| Mar-31-23 | Initiated | B. Riley Securities | Buy |
| Mar-10-23 | Upgrade | Citigroup | Sell → Neutral |
| Feb-07-23 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Nov-22-22 | Initiated | BofA Securities | Buy |
| Jul-11-22 | Downgrade | Citigroup | Neutral → Sell |
| Apr-06-22 | Initiated | Wolfe Research | Outperform |
| Nov-19-21 | Upgrade | Citigroup | Sell → Neutral |
| Oct-01-21 | Downgrade | Citigroup | Neutral → Sell |
| Oct-01-20 | Downgrade | Citigroup | Buy → Neutral |
| Aug-21-20 | Initiated | Piper Sandler | Neutral |
| Jul-09-20 | Initiated | SVB Leerink | Outperform |
| May-27-20 | Initiated | Citigroup | Buy |
| Aug-20-19 | Initiated | Argus | Buy |
| Apr-29-19 | Initiated | BMO Capital Markets | Outperform |
| Apr-29-19 | Initiated | BofA/Merrill | Neutral |
| Apr-29-19 | Initiated | JP Morgan | Overweight |
| Apr-29-19 | Initiated | Stifel | Buy |
View All
Silk Road Medical Inc Stock (SILK) Latest News
BSX Stock Rises Following Bolt Medical Acquisition Deal Announcement - Yahoo Finance Australia
Boston Scientific Paying Up To $664M For Bolt Medical - Law360
$1.26 Billion Bet To Eliminate Strokes: Boston Scientific's Acquisition of Silk Road Medical - Oficjalny Portal Gminy Brzesko
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SILK, ALIM, INFN on Behalf of Shareholders - The Eastern Progress Online
SILK INVESTIGATION: The M&A Class Action Firm Continues to Investigate the Merger and Looming Vote on September 5, 2024, of Silk Road Medical, Inc. - The Eastern Progress Online
Erica Rogers Joins Axena Health Board of Directors - citybiz
Erica Rogers Joins the Board of Directors at Axena Health, Bringing Proven Commercial Leadership and Expertise in Groundbreaking Healthcare Solutions - Business Wire
Buoyed by billion-dollar deals, its stock is up 50% this year. How did Boston Scientific get its mojo back? - STAT
Silk Road Medical Announce ROADSTER 3 Clinical Trial Results - MPO-mag
Boston Scientific continues M&A run with Cortex buy - MedTech Dive
Should You Buy Silk Road Medical Inc (SILK) Stock After it Is Down 16.04% in a Week? - InvestorsObserver
[Latest] Global Embolic Protection Device Market Size/Share - GlobeNewswire
Boston Scientific to close Silk Road Medical headquarters, lay off 138 people - MedTech Dive
Boston Scientific : 4 things to know about our acquisition of Silk Road Medical - Marketscreener.com
Boston Scientific Announces Results for Third Quarter 2024 - StockTitan
STOCKHOLDER INVESTIGATION: The M&A Class Action Firm Investigates Merger of Silk Road Medical, Inc.SILK - GuruFocus.com
Boston Scientific target raised on Silk Road deal By Investing.com - Investing.com UK
SMT Publishes Trial Results for Supraflex Cruz Stent - Diagnostic and Interventional Cardiology
Chinese pharmaceutical firms expand to Africa under ‘health silk road’ - South China Morning Post
September’s $375M value marks highest month for 2024 deals - BioWorld Online
Embolic Protection Devices Market Insights Discussed Regarding Analysis And Forecast 20242033 - WhaTech
Silk Road Medical, Inc (NASDAQ:SILK) Given Consensus Rating of “Reduce” by Brokerages - Defense World
Global Expansion, Strategic Innovations Aid Boston Scientific Stock - Yahoo Finance
Vascular Embolization Market Growth, Size, Analysis And Forecast 2024-2033 - WhaTech
Peripheral Artery Disease Market Report 2024: Global Size, Growth, Trends, Forecast to 2033 - WhaTech
Silk Road Medical (NASDAQ:SILK) versus West Pharmaceutical Services (NYSE:WST) Financial Analysis - Defense World
Slotnik Capital LLC Acquires Shares of 300,000 Silk Road Medical, Inc (NASDAQ:SILK) - Defense World
Sagefield Capital LP Invests $1.58 Million in Silk Road Medical, Inc (NASDAQ:SILK) - Defense World
Silk Road Medical, Inc (NASDAQ:SILK) Shares Acquired by Gabelli Funds LLC - Defense World
Glazer Capital LLC Takes $16.77 Million Position in Silk Road Medical, Inc (NASDAQ:SILK) - Defense World
Apis Capital Advisors LLC Buys New Position in Silk Road Medical, Inc (NASDAQ:SILK) - MarketBeat
CVRx Gains Two New Board Members - MPO-mag
Magnetar Financial LLC Makes New $53.28 Million Investment in Silk Road Medical, Inc (NASDAQ:SILK) - Defense World
Apis Capital Advisors LLC Takes $2.76 Million Position in Silk Road Medical, Inc (NASDAQ:SILK) - Defense World
First Eagle Investment Management LLC Boosts Position in Silk Road Medical, Inc (NASDAQ:SILK) - MarketBeat
Rhumbline Advisers Acquires 5,327 Shares of Silk Road Medical, Inc (NASDAQ:SILK) - Defense World
MPO's Most-Read Stories This Week—Sept. 21 - MPO-mag
Drug-Eluting Stent or Primary Bare Nitinol Stent Application vs DCB|VDM - HMP Global Learning Network
Quest Partners LLC Decreases Holdings in Silk Road Medical, Inc (NASDAQ:SILK) - Defense World
Boston Scientific completes acquisition of Silk Road Medical - Vascular News
Boston Scientific closes Silk Road Medical acquisition - Medical Buyer
10,418 Shares in Silk Road Medical, Inc (NASDAQ:SILK) Bought by Arizona State Retirement System - Defense World
Boston Scientific Closes Silk Road Medical Acquisition - citybiz
Boston Scientific Closes Acquisition of Silk Road Medical, Inc. - The Malaysian Reserve
Boston Scientific: Why This MedTech Giant Isn't Slowing Down - MSN
Boston Scientific acquires Silk Road Medical - Investing.com
Boston Scientific Closes Acquisition Of Silk Road Medical - MPO-mag
Boston Scientific acquires Silk Road Medical By Investing.com - Investing.com Australia
Silk Road Medical Completes Merger and Resolves Financial Obligations - TipRanks
Boston Scientific closes acquisition of Silk Road Medical - TipRanks
Acquisition News Lifted Silk Road Medical (SILK) in Q2 - Insider Monkey
Silk Road Medical Inc Stock (SILK) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.10%
0.74%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):